학술논문

177P Pertuzumab (P) as ≥ second-line therapy for HER2-positive metastatic breast cancer (mBC): Swiss clinical experience.
Document Type
Article
Source
Annals of Oncology. 2019 Supplement, Vol. 30, pN.PAG-N.PAG. 1p. 1 Chart.
Subject
*HORMONE receptor positive breast cancer
*METASTATIC breast cancer
*THERAPEUTICS
Language
ISSN
0923-7534